Cargando…
The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma
Background: Little is known about the prognostic significance of somatically mutated genes in metastatic melanoma (MM). We have employed a combined clinical and bioinformatics approach on tumor samples from cutaneous melanoma (SKCM) as part of The Cancer Genome Atlas project (TCGA) to identify mutat...
Autores principales: | Zhao, Xiaobei, Little, Paul, Hoyle, Alan P., Pegna, Guillaume J., Hayward, Michele C., Ivanova, Anastasia, Parker, Joel S., Marron, David L., Soloway, Matthew G., Jo, Heejoon, Salazar, Ashley H., Papakonstantinou, Michael P., Bouchard, Deeanna M., Jefferys, Stuart R., Hoadley, Katherine A., Ollila, David W., Frank, Jill S., Thomas, Nancy E., Googe, Paul B., Ezzell, Ashley J., Collichio, Frances A., Lee, Carrie B., Earp, H. Shelton, Sharpless, Norman E., Hugo, Willy, Wilmott, James S., Quek, Camelia, Waddell, Nicola, Johansson, Peter A., Thompson, John F., Hayward, Nicholas K., Mann, Graham J., Lo, Roger S., Johnson, Douglas B., Scolyer, Richard A., Hayes, D. Neil, Moschos, Stergios J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329304/ https://www.ncbi.nlm.nih.gov/pubmed/30662871 http://dx.doi.org/10.3389/fonc.2018.00584 |
Ejemplares similares
-
Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC
por: Zhao, Xiaobei, et al.
Publicado: (2015) -
SCISSOR: a framework for identifying structural changes in RNA transcripts
por: Choi, Hyo Young, et al.
Publicado: (2021) -
UNMASC: tumor-only variant calling with unmatched normal controls
por: Little, Paul, et al.
Publicado: (2021) -
The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma
por: Karachaliou, Georgia Sofia, et al.
Publicado: (2022) -
Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanoma
por: Oldan, Jorge D., et al.
Publicado: (2023)